New Mexico cannabis sales steady as border towns drive growth
New Mexico cannabis sales are holding steady in 2026, with the latest sales figures suggesting the state has…
Second major cannabis MSO sues New Jersey over labor law
A second major marijuana multistate operator is going to federal court to challenge a licensing requirement friendly to…
Turning Interest Into Advocacy: Why You Should Intern With NORML
NORML Summer ‘26 Intern Dakota Helgren shares her experience for The post Turning Interest Into Advocacy: Why You…
Michigan cannabis retailer wins fight with city over Flock camera
Amid a nationwide uproar over privacy, city authorities in a Detroit suburb have removed a Flock surveillance camera…
Feds: Over 1 in 5 Older Adults Have Consumed Cannabis in the Past Year
“Many older adults are aware of the litany of serious adverse side-effects associated with available prescription drugs, like…
New Jersey cannabis regulators appeal labor fight loss to Curaleaf
In a case with serious national implications for cannabis labor relations, state regulators in New Jersey are appealing…
Massachusetts: Democrats Overwhelmingly Reject Ballot Proposal to Repeal Adult-Use Marijuana Legalization
“There’s no ‘buyer’s remorse’ among Massachusetts’ voters when it comes to legalizing cannabis and this fact will become…
California county cuts cannabis taxes after short-lived increase
In an echo of last year’s statewide cannabis excise tax controversy, a central California county will cut its…
Sanity acquisition drives Organigram to record Q3 revenue
Organigram Global, one of Canada’s largest cannabis producers, reported record third-quarter revenue Tuesday, gains driven by its acquisition…
How federal marijuana rescheduling affects cannabis trademarks
Key points: Federal marijuana rescheduling creates new opportunities for Schedule 3-compliant medical cannabis operators to protect their intellectual…
US marijuana MSO Curaleaf plots hostile takeover of Aurora Cannabis
U.S.-based marijuana multistate operator Curaleaf Holdings wants to buy out Canadian licensed producer Aurora Cannabis. And after Aurora’s…
NORML Op-Ed: High Time to Remove Cannabis from Schedule I Status
Cannabis does not possess the same risks to health as do other Schedule I substances like heroin, or…
Clinical Trial: Plant-Derived Cannabis Preparation Is Safe and Effective in Children with Autism
Patients’ disease severity fell an estimated 2 points on a 7-point scale following eight weeks of cannabinoid treatment.…